Realm Therapeutics plc — Form D/A
Realm Therapeutics plc of LONDON, X0, a company, filed a Form D amendment with the SEC on 2017-10-25. The offering totals $20.5M, of which $20.5M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2017-10-25
- Form: D/A
- Accession: 0001231919-17-000046
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $20.5M
- Amount sold: $20.5M
- Investors: 8
- Date of first sale: 2017-10-10
- Security types: equity
- Revenue range: $1 - $1,000,000
- SEC file number: 021-296823
Issuer
- Name: Realm Therapeutics plc
- CIK: 0001718903
- Entity type: Corporation
- Jurisdiction: UNITED KINGDOM
- Address: CANNON PLACE, LONDON, X0, EC4N 6AF
- Phone: 484-321-2700
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Joseph William Birkett | Director | London, X0 |
| Ivan William Gergel | Director | London, X0 |
| Balkrishan William Gill | Director | London, X0 |
| Matthew William Hammond | Director | London, X0 |
| Daniel William Hegglin | Director | London, X0 |
| Alex Martin | Director | Frederick, MD |
| Charles Spicer | Director | London, X0 |
| Marella Thorell | Director | London, X0 |
| Alex Martin | Executive Officer | Frederick, MD |
| Marella Thorell | Executive Officer | London, X0 |
Other filings by this issuer (1)
More